Home / United Kingdom / GW Pharmaceuticals PLC

GW Pharmaceuticals PLC

No short position is open on this share today.

0.00% of the capital sold short

0 disclosing funds

470 disclosures on record

Evolution of the disclosed total

0%1%

Oct 2025Jan 2026Apr 2026Jul 2026

Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

Over the whole history, the total peaked at 5.93% on August 1, 2014. The shaded band matches the twelve months of the first chart.

April 25, 2014 today

Open positions

No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.

Follow by RSS

Get the moves on GW Pharmaceuticals PLC by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

470 disclosures on record for this share.
Date	Fund	% of capital
October 11, 2016	City Financial Investment Company Limited	0.55%
October 10, 2016	Marshall Wace LLP	2.00%
October 7, 2016	D. E. Shaw & CO. LP	0.74%
October 6, 2016	Marshall Wace LLP	1.92%
October 6, 2016	D. E. Shaw & CO. LP	0.63%
October 5, 2016	D. E. Shaw & CO. LP	0.57%
October 5, 2016	Worldquant LLC	0.50%
October 4, 2016	Marshall Wace LLP	1.83%
October 3, 2016	PDT Partners, LLC	0.59%
October 3, 2016	Worldquant LLC	0.46%
September 30, 2016	D. E. Shaw & CO. LP	0.69%
September 30, 2016	PDT Partners, LLC	0.60%
September 29, 2016	Marshall Wace LLP	1.70%
September 27, 2016	PDT Partners, LLC	0.53%
September 26, 2016	Marshall Wace LLP	1.60%
September 26, 2016	D. E. Shaw & CO. LP	0.72%
September 26, 2016	PDT Partners, LLC	0.64%
September 26, 2016	Partner Fund Management, L.P.	0.15%
September 26, 2016	Millennium International Management LP	0.14%
September 23, 2016	Millennium International Management LP	0.69%
September 23, 2016	D. E. Shaw & CO. LP	0.65%
September 22, 2016	PDT Partners, LLC	0.78%
September 21, 2016	D. E. Shaw & CO. LP	0.78%
September 20, 2016	D. E. Shaw & CO. LP	0.82%
September 19, 2016	Marshall Wace LLP	1.50%
September 16, 2016	D. E. Shaw & CO. LP	0.99%
September 15, 2016	Marshall Wace LLP	1.43%
September 15, 2016	PDT Partners, LLC	0.89%
September 15, 2016	Worldquant LLC	0.57%
September 13, 2016	D. E. Shaw & CO. LP	1.04%
September 12, 2016	Marshall Wace LLP	1.39%
September 12, 2016	D. E. Shaw & CO. LP	1.12%
September 9, 2016	D. E. Shaw & CO. LP	1.24%
September 9, 2016	PDT Partners, LLC	0.94%
September 9, 2016	Partner Fund Management, L.P.	0.69%
September 8, 2016	D. E. Shaw & CO. LP	1.46%
September 8, 2016	Marshall Wace LLP	1.41%
September 8, 2016	PDT Partners, LLC	0.75%
September 7, 2016	D. E. Shaw & CO. LP	1.68%
September 7, 2016	Marshall Wace LLP	1.32%
September 5, 2016	D. E. Shaw & CO. LP	1.31%
September 2, 2016	D. E. Shaw & CO. LP	1.31%
August 31, 2016	D. E. Shaw & CO. LP	1.22%
August 25, 2016	D. E. Shaw & CO. LP	1.11%
August 24, 2016	Marshall Wace LLP	1.22%
August 24, 2016	D. E. Shaw & CO. LP	1.07%
August 23, 2016	D. E. Shaw & CO. LP	1.10%
August 18, 2016	D. E. Shaw & CO. LP	1.04%
August 16, 2016	D. E. Shaw & CO. LP	0.90%
August 15, 2016	D. E. Shaw & CO. LP	1.03%

Download 470 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in the United Kingdom

Vistry Group PLC 17.06% of the capital sold short
Capita PLC 13.72% of the capital sold short
WH Smith PLC 13.30% of the capital sold short
Ceres Power Holdings PLC 13.26% of the capital sold short
Genuit Group PLC 12.04% of the capital sold short
Yellow Cake PLC 11.78% of the capital sold short
Ocado Group PLC 11.71% of the capital sold short
Chemring Group PLC 11.70% of the capital sold short
Crest Nicholson Holdings PLC 11.42% of the capital sold short
Wizz Air Holdings PLC 10.90% of the capital sold short
Breedon Group Plc 10.71% of the capital sold short
Greggs PLC 10.47% of the capital sold short

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, GW Pharmaceuticals PLC, source FCA, data as at February 11, 2020, https://www.quivad.com/action/gw-pharmaceuticals-plc?page=2